Location of Repository

Herpes zoster in multiple myeloma patients during bortezomib treatment

By I. N. Nazarova, M. N. Protasova and N. A. Nikishina


<p>Recent advances in multiple myeloma (MM) treatment associated with new drug use including bortezomib. Experiences in wide ambul atory drug use confirm therapy success for this serious disease, but at the same time reveals the most common side effects. One of th e most significant is the reactivation of Herpes zoster , which leads to decrease MM therapy results because of inability to perform standard therapy in these patients. Literature data and own experiences about reactivation of Herpes zoster during bortezomib therapy as monothe rapy and in combination, which varies from 7 to 34% according to different authors and 25% of own experiences, is presented. Treatment and preventive schedule of this complication are shown.</p

Topics: multiple myeloma, bortezomib, Herpes zoster, antiviral therapy aciclovir, Diseases of the blood and blood-forming organs, RC633-647.5
Publisher: ABV-press
Year: 2011
OAI identifier: oai:doaj.org/article:001ec460c7d647f5b60999f930d39ef7
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/2413-4023 (external link)
  • https://doaj.org/toc/1818-8346 (external link)
  • http://oncohematology.abvpress... (external link)
  • https://doaj.org/article/001ec... (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.